# Early Drug Development Group (E2DG)

> Oncology drug development support

Business model and tags: Pharma & life sciences, Has in-house R&D

## About Early Drug Development Group (E2DG)

Support throughout oncology drug development lifecycle including preclinical studies, clinical trial design, regulatory guidance, and strategic partnerships for R&D optimization.

## Key facts

- **Industry**: Pharmaceutical Manufacturing
- **Company size**: 1–10 employees
- **Headquarters**: Boulogne-Billancourt, Île-de-France, France
- **Founded**: 2015
- **Website**: [theinvestorscentre.com](https://theinvestorscentre.com/)
- **LinkedIn**: [linkedin.com/company/early-drug-development-group](https://www.linkedin.com/company/early-drug-development-group)

## Early Drug Development Group (E2DG) at a glance

Early Drug Development Group (E2DG) is a company in the Pharmaceutical Manufacturing industry, headquartered in Boulogne-Billancourt, Île-de-France, France.

Early Drug Development Group (E2DG) was founded in 2015.

Early Drug Development Group (E2DG) has 1–10 employees.

## Frequently asked questions about Early Drug Development Group (E2DG)

### How many employees does Early Drug Development Group (E2DG) have?

Early Drug Development Group (E2DG) has 1–10 employees.

### Where is Early Drug Development Group (E2DG) headquartered?

Early Drug Development Group (E2DG) is headquartered in Boulogne-Billancourt, Île-de-France, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/early-drug-development-group-e2dg
